Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin AmyloidosisDavid Adams, Ole B. Suhr, Teresa Coelho et al.|New England Journal of Medicine|2018Cited by 2.9k
Safety and Efficacy of RNAi Therapy for Transthyretin AmyloidosisTeresa Coelho, Ole B. Suhr, David Adams et al.|New England Journal of Medicine|2013Cited by 961
Repurposing Diflunisal for Familial Amyloid PolyneuropathyJohn L. Berk, P. James B. Dyck, Ole B. Suhr et al.|JAMA|2013Cited by 701
Clinical improvement and amyloid regression after liver transplantation in hereditary transthyretin amyloidosisGösta Holmgren, Mark B. Pepys, Lars Steen et al.|The Lancet|1993Cited by 581